Beat the Market Biotechs Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Beat the Market Biotechs

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

From: Western Rookie	3/20/2012 1:36:26 PM
	of 72

Sector Volume Alert - BIO TECHS!!! I am a volume guy when I look for themes that look attractive for the year. It worked extremely well identifying the tech theme last year with companies like INT, SCG, FSW, OPL etc. going on massive runs and this year I have identified Bio Techs as a place you want to park your dollars. This sector looks to be coming alive from what has been a prolonged slump for many companies. If you look at chart after chart of these junior Canadian companies, it clearly shows that this often ignored sector in favor of materials and energy is finally getting a bit of attention. Companies that I have identified big volume days in the last 2 months that show accumulation in this sector and willingness to buy in VOLUME... Chemaphor - CFR-V $0.095Medex Health Corp - MDX-V $0.235Sirona Biochem Corp - SBM-V $0.125Miraculins Inc. - MOM-V $0.15 Other companies volumes have increased significantly over the last year including... Neptune Biotech - NTB-T biOasis Technologies - BTI-V In Neptune's case, they are an industry leader and their volume really started increasing early on in 2011. The company has corrected in a very nice pattern and looks to be moving up to previously established highs in 2011. Biotechs, pharmaceuticals and health care stocks in general are the next big Investing Supercycle. Mining has been great, nor is it over... but over the next few years you want to be moving some cash over into this sector because of relative value. I expect Biotechs to eventually perform just like the Tech bubble did in the nineties. BIO TECH Watchlist... MDX-V MedX Health Corp - MoleMate - Skin Cancer Imaging System - Health Canada Approval $7.8M market cap. CFR-V Chemaphor - *Oximunol chewables* - Oxidized Beta Carotene - 3 Stage Commercialization... $7.5M market cap Animal health 2012Livestock Indsutry 2013 - potential to replace antibiotics in the feed industryHuman health 2014 - enchanced immune function MOM-V Miraculins - PreVu POC Test - Reads skin Cholesterol and helps evaluate a patients risk for coronary Artery Disease CAD. FDA Approval $10M market cap. SBM-V Sirona Biotech Corp - Specialize in producing carbohydrate based molecules. which maximizes the commercial value of carbohydrate based drugs. Apply technology across a diabetes therapeutics, cosmetic agents and biological ingredients. $7M market cap VRS-V Verisante Technologies - *Verisante Aura* - Non-invasive cancer detection devices taht offer physicians immediate results for many common types of Cancer. $41.3M market cap FLU-C Abattis Biologix - *Neutraceutical product development company* - Krill Oil / Nitric Oxide / DefenZall / FastFlu / Saskatoon Berries / Acai - $3.6M market cap NTB-T Netpune Technologies and Bioressources Inc - NKO - Krill Oil. Company is purely krill oil. $151M market cap APO-V Acasti Pharma Inc. - Neptune's pharma division developing safe and effective pharmaceutical and medical applications with an initial focus on cardiovascular disease by leveraging the intellectual property, clinical data and know how developed by Neptune Technologies. $155M market cap. BTI-V biOasis Technologies - *Transcend* - combines Transcend with other drugs to break the Blood Brain Barrier. $49M market cap KLH-V Stellar Biotechnologies - KLH - KLH is an important protein used in wide-ranging therapeutic and diagnostic markets. Vital component for vaccines (cancer, autoimmune and infectious disease) and an antigen for measuring immune status. $17.5M market cap

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next